Integration of High Throughput ‘Omic Platforms into Antibody Discovery

Video   Dec 23, 2016

 

From antibodies to vaccines to T cells, cancer immunotherapy is extending patient lives. Targeted therapies using immune cell receptors can be targeted to either cancer or immune cells. In pursuit of lead structures, ‘omic technologies are revolutionizing the discovery and development of novel biological lead structures. However, ‘omic platforms are first and foremost data generation instruments that require careful integration into workflows. Here, we demonstrate how we have applied next-generation sequencing, big data, biostatistics, and computational immunology to the discovery and development of novel lead structures.

 
 
 
 

Recommended Videos

Therapeutic Antibodies: Antibody-Drug Conjugates

Video

This is the third video in a three-part series of animations about therapeutic antibodies. This video focuses on antibody-drug conjugates.

WATCH NOW

Lumpy Skin Disease Vaccination Programme in Europe

Video

In January 2016 a number of countries in South East Europe started vaccinating cattle against lumpy skin disease. As the programme has progressed the number of outbreaks has fallen and by the end of 2017 the outbreaks had been contained.

WATCH NOW

Therapeutic Antibodies: Mechanism of Action

Video

This is the second video in a three-part series of animations about therapeutic antibodies. This video focuses on antibody 'mechanism of action'.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE